Laurus Labs Share Price Rises 2.10% After Q1 FY27 Results
- July 27, 2026
- Posted by: Kashish Aggarwal
- Category: Market
Laurus Labs share price rose 2.10% on Q1 results. Laurus Labs reported exceptional Q1 FY27 results, with consolidated net profit surging 126 percent year on year to Rs 362 crore and EBITDA margins exp
Laurus Labs share price rose 2.10%, moving from Rs 1,568.30 to Rs 1,601.20, after the company’s Q1 FY27 results. Laurus Labs reported exceptional Q1 FY27 results, with consolidated net profit surging 126 percent year on year to Rs 362 crore and EBITDA margins expanding to 31.8 percent.
The move reflects how the market weighed Laurus Labs’s quarterly numbers against broader sector and valuation context on results day.
Click Here – Get Free Investment Predictions
Laurus Labs Q1 FY27 Results: Key Numbers
The pharma company’s strong margin expansion alongside profit growth drove positive investor sentiment on results day.
| Metric | Detail |
|---|---|
| Laurus Labs | Q1 FY27 results |
| Share Price Reaction | Up 2.10% (Rs 1,568.30 to Rs 1,601.20) |
Univest – A SEBI-Registered Investment Advisor
Investors tracking the Laurus Labs share price should watch management commentary and subsequent brokerage notes for a fuller read on the quarter.
The stock has now moved from Rs 1,568.30 to Rs 1,601.20 between 23 July and 24 July, a period that captures the market’s initial digestion of the quarterly numbers.
Download the Univest iOS App or Univest Android App to track live Laurus Labs share price movements.
Why Did the Stock React This Way
The Laurus Labs share price rose 2.10% as investors weighed the Q1 FY27 print against expectations, valuation and broader market conditions on the day of the results.
Markets typically weigh both the headline profit and revenue trend alongside management’s forward commentary, and Laurus Labs’s reaction on the day reflects that broader assessment rather than any single data point in isolation.
Conclusion
Laurus Labs share price rose 2.10% after the company’s Q1 FY27 results. Laurus Labs reported exceptional Q1 FY27 results, with consolidated net profit surging 126 percent year on year to Rs 362 crore and EBITDA margins expanding to 31.8 percent. Investors should track the company’s subsequent brokerage commentary and consult a SEBI-registered advisor before making investment decisions.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions FAQs
Why did the Laurus Labs share price move after Q1 results?
Ans. The Laurus Labs share price gained 2.10 percent, moving from Rs 1,568.30 to Rs 1,601.20, after Laurus Labs released its Q1 FY27 results. Laurus Labs reported exceptional Q1 FY27 results, with consolidated net profit surging 126 percent year on year to Rs 362 crore and EBITDA margins expanding to 31.8 percent.
What was Laurus Labs’s Q1 FY27 result highlight?
Ans. Laurus Labs reported exceptional Q1 FY27 results, with consolidated net profit surging 126 percent year on year to Rs 362 crore and EBITDA margins expanding to 31.8 percent.
How much did the Laurus Labs share price move around the results?
Ans. The Laurus Labs share price moved up 2.10 percent from Rs 1,568.30 to Rs 1,601.20 around the Q1 FY27 results.
Should investors buy Laurus Labs after this move?
Ans. Investors should review the company’s full Q1 FY27 results, management commentary and valuation before making any decision, and are advised to consult a SEBI-registered advisor.
Where can I track live Laurus Labs updates?
Ans. Live Laurus Labs share price updates, charts and financials are available on the Univest platform and app.
What should investors watch next for Laurus Labs?
Ans. Investors should track subsequent brokerage notes, management commentary on the earnings call, and the company’s performance in the following quarter for further clarity on the Laurus Labs share price trend.
